Belly fat predicts heart risks better than BMI
New research indicates that abdominal fat and waist size are more accurate predictors of cardiovascular risk than traditional Body Mass Index (BMI) measurements.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The findings suggest that measuring the area around the waist provides a more precise understanding of a patient's risk profile for cardiovascular events than the general BMI metric. This shift in focus moves the diagnostic priority toward the specific location of fat storage rather than overall weight relative to height. Coverage of this development is widespread across medical and general news outlets. Medical Xpress and The Telegraph both explicitly state that belly fat is a better predictor of heart risks than BMI.
Similarly, MedPage Today emphasizes that waist size matters significantly for cardiovascular risks, while Medscape reports that additional measures beyond BMI are more effective at predicting cardiovascular risk. The American College of Cardiology has also highlighted the role of central adiposity as a primary predictor of cardiovascular outcomes, framing the data within a clinical context. To understand why this is trending, it is necessary to recognize the longstanding reliance on BMI as a primary health screening tool. BMI calculates a ratio of weight to height but does not differentiate between muscle mass and fat, nor does it identify where fat is distributed in the body.
Because central adiposity—the accumulation of fat in the abdominal region—is linked more closely to heart disease, these new findings challenge the sufficiency of BMI as a standalone metric for assessing long-term heart health. Observers should monitor whether these findings lead to changes in official clinical guidelines for cardiovascular screening. Future reports may specify how health providers should incorporate waist measurements alongside or instead of BMI to assess patient risk. While the current coverage establishes that abdominal fat is a stronger predictor of heart disease, it remains to be seen if this will trigger a standardized shift in how cardiovascular outcomes are predicted across global healthcare systems.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (92% supported) Updated 94d ago.
Quick answers
Why is abdominal fat a better predictor than BMI?
According to reports from Medical Xpress and MedPage Today, central adiposity and waist size are more closely linked to cardiovascular risks than the general BMI ratio.
Which organizations reported on these findings?
The findings were reported by Medscape, Medical Xpress, the American College of Cardiology, MedPage Today, and The Telegraph.
What does central adiposity refer to?
Based on the coverage, central adiposity refers to abdominal fat or the size of the waist as a measure of cardiovascular risk.
Coverage (21)
- Waist size is a powerful indicator of health risks, researchers find Medical Xpress · 92d ago
- What Is Waist-to-Hip Ratio? Yahoo Health · 92d ago
- Belly fat may be a better predictor of heart disease risk than BMI, study finds ABC News - Breaking News, Latest News and Videos · 92d ago
- Central Adiposity Gives Greater Insight Into CV Risk Than BMI TCTMD.com · 93d ago
- Why some people classified as obese may have lower heart risks than expected News 5 Cleveland WEWS · 94d ago
- Heart Disease: Belly Fat May Predict Risk Better Than BMI Healthline · 94d ago
- HOMETOWN HEALTH: Waistline measurements indicating risk for heart disease WDBJ7 · 94d ago
- Study finds belly size beats BMI at predicting heart attacks cbs19news.com · 94d ago
- Study finds belly size beats BMI at predicting heart attacks klax-tv.com · 94d ago
- Study finds belly size beats BMI at predicting heart attacks The Mountaineer · 94d ago
- BMI alone is not enough: Abdominal fat plays crucial role when assessing heart disease risk Cardiovascular Business · 94d ago
- Study finds belly size beats BMI at predicting heart attacks Marietta Daily Journal · 94d ago
- Study finds belly size beats BMI at predicting heart attacks Vermont Community Newspaper Group · 94d ago
- Waist size predicts heart disease risk better than body mass index News-Medical · 94d ago
- Abdominal Fat May Predict Heart Disease Risk Better Than BMI Bioengineer.org · 94d ago
- Study finds belly size beats BMI at predicting heart attacks hpenews.com · 94d ago
- Beyond BMI: Additional Measures Better Predict CV Risk Medscape · 94d ago
- Abdominal fat predicts heart disease risk better than BMI, study shows Medical Xpress · 94d ago
- Central Adiposity as Predictor of CV Outcomes American College of Cardiology · 94d ago
- BMI Aside, Waist Size Matters for Cardiovascular Risks MedPage Today · 94d ago
- Belly fat predicts heart risks better than BMI The Telegraph · 94d ago
Topics
Related trends
Does a heart stent prevent future heart attacks in stable patients? 25-year follow-up offers new insight
25-year study reveals new insight on heart stents in stable patients
Strokes are happening younger; reasons and risk factors, including possible link to cannabis use
Recent coverage tracks a rising incidence of strokes and heart disease among young adults in their twenties and thirties.
Why heart attacks can still happen even when bad cholesterol is low
New medical coverage explores why heart attacks can still occur in adults who maintain normal, low levels of bad cholesterol.
Column | Your stroke risk is 72 percent higher during these 3 hours of the day
Multiple outlets report stroke risk spikes 72 percent higher during a specific three-hour morning window, citing new medical research.
Could This Everyday Drink Help Your Heart? A Study of Nearly 500,000 People Offers New Evidence
New research involving nearly 500,000 people examines how drinking tea may protect vascular health and lower heart disease risk.
Pelacarsen, a promising drug for an inherited heart risk, flops, stunning doctors
Medical experts are stunned after the promising cholesterol drug pelacarsen unexpectedly fails a key study, leading to its abandonment.